Related Experiment Video
Updated: Aug 6, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Danazol treatment increases serum enzyme levels
Abstract:
Six of seven women treated for endometriosis with daily administrations of 800 mg of danazol over 4.7 to 9 months developed one or more mildly abnormal serum enzyme levels. All seven patients had normal pretreatment enzyme levels and were evaluated after 2.5 to 5 months of drug therapy and again 1 to 2.5 months following completion of drug therapy. Danazol therapy was associated with statistically significant increases in the following serum enzyme levels: creatine phosphokinase, lactate dehydrogenase, serum glutamic oxaloacetic transaminase, and serum glutamic pyruvic transaminase. Mean serum enzyme increases ranged from 25% to 86% greater than the mean pre-drug-therapy level. Alkaline phosphatase levels were not altered by the danazol treatment. Following completion of danazol therapy, all enzyme levels were within the normal range except serum glutamic pyruvic transaminase, which was approaching normal. High-dose danazol treatment (800 mg daily) is associated with mild elevations of specific serum enzymes, and these changes appear to resolve spontaneously after cessation of treatment.
More Related Videos
11:06Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
14:18Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
Related Concept Videos
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Therapeutic Drug Monitoring: Drug Analysis Methods
Pharmacokinetics: Drug–Drug Interactions
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug toxicity: Drug–Drug Interaction
Serum Studies: Renal Function Tests